PAI-1
抑制剂选择性比较
PAI-1产品
目录号 | 产品描述 | 文献引用 | 实验数据 |
---|---|---|---|
S9194 |
ToddalolactoneToddalolactone, a natural coumarin, inhibits the activity of recombinant human Plasminogen activator inhibitor-1 (PAI-1) in a dose-dependent manner, yielding an IC50 value of 37.31 ± 3.23 μM. |
||
S7922 |
Tiplaxtinin (PAI-039)Tiplaxtinin(PAI-039)是口服有效的选择性纤溶酶原激活物抑制剂-1(PAI-1)抑制剂,IC50为2.7 μM。 |
![]() ![]() (H) IF indicating Pcna+ and GFP+ cells after TP treatment (regime indicated at top). (I) Scatter plot of the relative number of Pcna+ cells among all wound and wound-adjacent GFP+ cells. Mean±s.d.; t-test, *P<0.05. (J) FISH combined with IHC showing that TP treatment increases cdh5 mRNA levels in GFP+ wound endocardium. (K) Scatter plot of relative red fluorescence intensity, comparing values of remote and wound endocardium (see Fig. 2F). Mean±s.d.; t-test, **P<0.01.
|
|
S3242New |
Loureirin BLoureirin B (LB, LrB),是从Dracaena cochinchinensis中提取的类黄酮,是 PAI-1 的抑制剂,其IC50值为26.10 μM。Loureirin B 可下调TGF-β1刺激的成纤维细胞中的 p-ERK 和 p-JNK。Loureirin B 主要通过增加Pdx-1、MafA、细胞内ATP水平来促进胰岛素分泌,抑制 KATP 电流,Ca2+ 进入细胞内。 |
||
S3785 |
Notoginsenoside R1Notoginsenoside R1 (Sanchinoside R1) is the main ingredient with cardiovascular activity in Panax notoginseng. It inhibits TNF-α-induced PAI-1 overexpression via extracellular signal-related kinases (ERK1/2) and phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling pathways. |
||
S6776New |
TM5275 SodiumTM 5275 sodium 是一种口服的、生物活性的 plasminogen activator inhibitor-1 (PAI-1) 抑制剂,其IC50值为6.95 μM。 |
||
S6778New |
TM5441TM5441是一种口服生物活性的 plasminogen activator inhibitor-1 (PAI-1) 抑制剂,其IC50值介于9.7 μM 和60.3 μM 之间。TM5441可诱导几种人类癌细胞系的内源性细胞凋亡。 |
目录号 | 产品描述 | 文献引用 | 实验数据 |
---|---|---|---|
S9194 |
ToddalolactoneToddalolactone, a natural coumarin, inhibits the activity of recombinant human Plasminogen activator inhibitor-1 (PAI-1) in a dose-dependent manner, yielding an IC50 value of 37.31 ± 3.23 μM. |
||
S7922 |
Tiplaxtinin (PAI-039)Tiplaxtinin(PAI-039)是口服有效的选择性纤溶酶原激活物抑制剂-1(PAI-1)抑制剂,IC50为2.7 μM。 |
![]() ![]() (H) IF indicating Pcna+ and GFP+ cells after TP treatment (regime indicated at top). (I) Scatter plot of the relative number of Pcna+ cells among all wound and wound-adjacent GFP+ cells. Mean±s.d.; t-test, *P<0.05. (J) FISH combined with IHC showing that TP treatment increases cdh5 mRNA levels in GFP+ wound endocardium. (K) Scatter plot of relative red fluorescence intensity, comparing values of remote and wound endocardium (see Fig. 2F). Mean±s.d.; t-test, **P<0.01.
|
|
S3242New |
Loureirin BLoureirin B (LB, LrB),是从Dracaena cochinchinensis中提取的类黄酮,是 PAI-1 的抑制剂,其IC50值为26.10 μM。Loureirin B 可下调TGF-β1刺激的成纤维细胞中的 p-ERK 和 p-JNK。Loureirin B 主要通过增加Pdx-1、MafA、细胞内ATP水平来促进胰岛素分泌,抑制 KATP 电流,Ca2+ 进入细胞内。 |
||
S3785 |
Notoginsenoside R1Notoginsenoside R1 (Sanchinoside R1) is the main ingredient with cardiovascular activity in Panax notoginseng. It inhibits TNF-α-induced PAI-1 overexpression via extracellular signal-related kinases (ERK1/2) and phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling pathways. |
||
S6776New |
TM5275 SodiumTM 5275 sodium 是一种口服的、生物活性的 plasminogen activator inhibitor-1 (PAI-1) 抑制剂,其IC50值为6.95 μM。 |
||
S6778New |
TM5441TM5441是一种口服生物活性的 plasminogen activator inhibitor-1 (PAI-1) 抑制剂,其IC50值介于9.7 μM 和60.3 μM 之间。TM5441可诱导几种人类癌细胞系的内源性细胞凋亡。 |